June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Generation of induced pluripotent stem cell-derived choroidal endothelial cells for the treatment of AMD
Author Affiliations & Notes
  • Allison E Songstad
    Ophthalmology, University of Iowa, Coralville, IA
  • Luke A Wiley
    Ophthalmology, University of Iowa, Coralville, IA
  • Cathryn Cranston
    Ophthalmology, University of Iowa, Coralville, IA
  • Miles Flamme-Wiese
    Ophthalmology, University of Iowa, Coralville, IA
  • Jeremy Hoffmann
    Ophthalmology, University of Iowa, Coralville, IA
  • Christine Haas
    Ophthalmology, University of Iowa, Coralville, IA
  • Edwin M Stone
    Ophthalmology, University of Iowa, Coralville, IA
  • Robert F Mullins
    Ophthalmology, University of Iowa, Coralville, IA
  • Budd Tucker
    Ophthalmology, University of Iowa, Coralville, IA
  • Footnotes
    Commercial Relationships Allison Songstad, None; Luke Wiley, None; Cathryn Cranston, None; Miles Flamme-Wiese, None; Jeremy Hoffmann, None; Christine Haas, None; Edwin Stone, None; Robert Mullins, None; Budd Tucker, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4200. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Allison E Songstad, Luke A Wiley, Cathryn Cranston, Miles Flamme-Wiese, Jeremy Hoffmann, Christine Haas, Edwin M Stone, Robert F Mullins, Budd Tucker; Generation of induced pluripotent stem cell-derived choroidal endothelial cells for the treatment of AMD. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4200.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Age-related macular degeneration (AMD), the most common cause of incurable blindness in the western world, involves the dysfunction and eventual death of choroidal endothelial, retinal pigment epithelial (RPE), and photoreceptor cells. Induced pluripotent stem cell (iPSC)-based strategies designed to replace both photoreceptor and RPE cells are currently a major scientific focus. For some patients, success of these approaches may also require replacement of choroidal endothelial cells (ECs). The purpose of this study was to generate choroidal ECs from two Tie2 GFP iPSC reporter lines to develop efficient differentiation and transplantation protocols.

Methods: Dermal fibroblasts from the Tie2 GFP mouse (carrying a GFP reporter gene under the control of the EC-specific Tie2 promoter) were isolated and reprogrammed into two iPSC lines via viral transduction of the transcription factors Oct4, Sox2, Klf4, and c-Myc. iPSC potency was characterized via RT-PCR, immunocytochemistry (ICC), and teratoma formation assays. Tie2 GFP iPSCs were differentiated into ECs using a co-culture method with either the RF6A choroidal EC line or primary mouse choroidal ECs. The Tie2 GFP iPSC-ECs from both lines were characterized via RT-PCR and ICC for various EC-specific and choroidal EC-specific markers.

Results: Both iPSC lines were subjected to co-culture with either the RF6A cell line or primary mouse choroidal ECs and differentiated into vascular ECs. The two Tie2-GFP iPSC-derived EC lines expressed the EC markers CD31, CD34, Tie2, VE-Cadherin, and VWF, as determined by RT-PCR, expressed the choroidal EC-specific markers ICAM1, as determined by RT-PCR, and carbonic anhydrase IV, as determined by RT-PCR and ICC, and were morphologically indistinguishable from native choroidal ECs that expressed ZO-1 and VE-Cadherin in cell-cell adhesions.

Conclusions: We have successfully generated Tie2 GFP iPSCs that can be efficiently differentiated into choroidal-like ECs. This work has paved the way for future studies focused on investigating AMD pathophysiology and EC replacement.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×